The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our ...

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...

Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...

The human brain can do many amazing things, but self-repair is not one of its repertoire of abilities. Once neurons die—from ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

A team of researchers at The University of Texas at Austin and the University of Porto have created a new way to target ...

Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...

The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...